Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Toxic encephalopathy due to ingestion of bismuth salts: clinical and EEG studies of 45 patients.

Literature DB >> 336849

Toxic encephalopathy due to ingestion of bismuth salts: clinical and EEG studies of 45 patients.

V Supino-Viterbo, C Sicard, M Risvegliato, G Rancurel, A Buge.

Abstract

Forty-five patients taking bismuth subnitrate orally for therapeutic reasons were admitted to hospital with a myoclonic encephalopathy of acute onset. The clinical features were similar, mostly with mental confusion, disorder of walking and standing, dysarthria, and myoclonic jerks. In 31 cases the EEG showed a characteristic pattern, not previously recognised, which assisted differential diagnosis.

Entities: Chemical Disease Species

Mesh：

Substances：
Bismuth

Year: 1977 PMID： 336849 PMCID： PMC492829 DOI： 10.1136/jnnp.40.8.748

Source DB: PubMed Journal: J Neurol Neurosurg Psychiatry ISSN： 0022-3050 Impact factor: 10.154

10 in total

1. [Reversible encephalopathies caused by bismuth salts. 5 further cases].

Authors: F Lhermitte; C F Degos; J L Signoret
Journal: Nouv Presse Med Date: 1975-02-08

2. A subacute progressive encephalopathy with mutism, hypokinesia, rigidity, and myoclonus.

Authors: C A PALLIS; J D SPILLANE
Journal: Q J Med Date: 1957-07

3. Clinical and electroencephalographic observations in Alzheimer's disease.

Authors: F LETEMENDIA; G PAMPIGLIONE
Journal: J Neurol Neurosurg Psychiatry Date: 1958-08 Impact factor: 10.154

4. Rapidly progressive cerebral degeneration (subacute vascular encephalopathy) with mental disorder, focal disturbances, and myoclonic epilepsy.

Authors: D P JONES; S NEVIN
Journal: J Neurol Neurosurg Psychiatry Date: 1954-05 Impact factor: 10.154

5. [Polygraphic study of bismuth-induced myoclonic encephalopathy].

Authors: J L Gastaut; C A Tassinari; G Terzano; I Picornell
Journal: Rev Electroencephalogr Neurophysiol Clin Date: 1975 Jul-Sep

6. [20 cases of acute encephalopathy with myoclonus during treatments with orally-administered bismuth salts].

Authors: A Buge; G Rancurel; M Poisson; J Gazengel; H Dechy; L Fressinaud; J Emile
Journal: Ann Med Interne (Paris) Date: 1974-12

7. Dose of influenza virus subunit vaccine.

Authors: N F Babbage; W Flower; P W Gill; D A Garrett; M L Wark; J M Tindale
Journal: Med J Aust Date: 1973-05-05 Impact factor: 7.738

8. [Myoclonic encephalopathies induced by bismuth salts. 6 cases observed during long-term oral treatment].

Authors: A Buge; G Rancurel; M Poisson; H Dechy
Journal: Nouv Presse Med Date: 1974-10-26

9. [Neuropathologic and toxicologic study of 12 cases of bismuth encephalopathy].

Authors: R Escourolle; R Bourdon; A Galli; P Galle; M C Jaudon; J J Hauw; F Gray
Journal: Rev Neurol (Paris) Date: 1977-03 Impact factor: 2.607

10. Reversible encephalopathy possibly associated with bismuth subgallate ingestion.

Authors: R Burns; D W Thomas; V J Barron
Journal: Br Med J Date: 1974-02-09

10 in total

12 in total

1. [Monoamine metabolites and cyclic nucleotides in the cerebrospinal fluid of patients with bismuth or mercury poisoning].

Authors: H Cramer; B Renaud; M Billiard; J Mouret; R Hammers
Journal: Arch Psychiatr Nervenkr (1970) Date: 1978-12-14

Toxic encephalopathy due to ingestion of bismuth salts: clinical and EEG studies of 45 patients.

1. [Reversible encephalopathies caused by bismuth salts. 5 further cases].

2. A subacute progressive encephalopathy with mutism, hypokinesia, rigidity, and myoclonus.

3. Clinical and electroencephalographic observations in Alzheimer's disease.

4. Rapidly progressive cerebral degeneration (subacute vascular encephalopathy) with mental disorder, focal disturbances, and myoclonic epilepsy.

5. [Polygraphic study of bismuth-induced myoclonic encephalopathy].

6. [20 cases of acute encephalopathy with myoclonus during treatments with orally-administered bismuth salts].

7. Dose of influenza virus subunit vaccine.

8. [Myoclonic encephalopathies induced by bismuth salts. 6 cases observed during long-term oral treatment].

9. [Neuropathologic and toxicologic study of 12 cases of bismuth encephalopathy].

10. Reversible encephalopathy possibly associated with bismuth subgallate ingestion.

1. [Monoamine metabolites and cyclic nucleotides in the cerebrospinal fluid of patients with bismuth or mercury poisoning].

2. Neuropsychiatric symptoms following bismuth intoxication.

Review 3. Relapse rate as a major determinant of drug selection in peptic ulcer therapy.

4. Absorption and elimination of bismuth from oral doses of tripotassium dicitrato bismuthate.

5. Comparison between cimetidine and Caved-S in the treatment of gastric ulceration, and subsequent maintenance therapy.

Review 6. Renal effects of peptic ulcer therapy.

Review 7. Drug-induced myoclonus: frequency, mechanisms and management.

8. Disposition of bismuth in the rat. I. Red blood cell and plasma protein binding.

Review 9. Pharmacokinetics and toxicity of bismuth compounds.

10. Epileptic phenomena in bismuth toxic encephalopathy.